[1] Qureshi K, Abrams GA. Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of non-alcoholic fatty liver disease [J].World Gastroenterol,2007, 13(26):3540-3553. [2] Gao B, Jeong WI, Tian Z. Liver:an organ with predominant innate immunity[J] .Hepatology,2008,47(2):729-736. [3] 楚玉兰,顾洪立,兰继,等.慢性乙型肝炎及后期肝病患者外周血T淋巴细胞亚群标志的研究[J].实用预防医学,2016,23(7):873-875. [4] Zhou Y, Callendret B,Dan Xu,et al. Dominance of the CD4+T helper cell response during acute resolving hepatitis A vitus infection [J]. J Exp Med,2012,209(8):1481-1492. [5] 李元元,王立峰,耿华,等.自身免疫性肝病患者外周血淋巴细胞亚群的频率变化及临床意义[J].临床肝胆病杂志,2014,30(5):409-412. [6] 张红梅,张明,郜志美.自身免疫性肝炎患者外周血淋巴细胞亚群的变化[J].实用肝脏病杂志,2015,18(1):76-77. [7] Liberal R ,Grant CR,Mieli-Vergani G,et al. Autoimmune hepatitis:a comprehensive review[J].J Autoimmun,2013,41:126-139. [8] Wang Q, Zheng Y, Huang Z, et al. Activated IL-23/IL-17 pathway closely correlates with increased FoxP3 expression in livers of chronic hepatitis B patients[J]. BMC Immunol, 2011,12(2):25-28. [9] 邓敏, 李明慧, 刘顺爱, 等. 慢性HBV感染者调节性T细胞水平及FoxP3与CD127表达关系的研究[J]. 中华实验和临床病毒学杂志, 2010, 24(1): 21-23. [10] Nan XP, Zhang Y, Yu HT, et al. Circulating CD4+CD25 high regulatory T cells and expression of PD-1 and BTLA on CD4+ T cells in patients with chronic hepatitis B virus infection[J]. Viral Immunol, 2010, 23(1):63-70. [11] 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南(2010年修订版)[J]. 中华肝脏病杂志,2010,34(18):163-166. [12] Dong Z,Wei H,Sun R, et al. The roles of innate immune cells in liver injury and regeneration[J]. Cell Immunol, 2007, 49(4):241-252. [13] 刘一新,黄玉政,仝德胜,等. 非酒精性脂肪性肝病患者外周血淋巴细胞亚群的变化及意义[J] .中国现代医药杂志,2011,13(1):32-34. [14] 杨丽丽,柳涛,王淼,等. 氧化应激与非酒精性脂肪性肝病研究进展[J]. 世界华人消化杂志,2009, 17(9):896-900.
2018, Vol. 25 
